PEGylation & Chemical modification
Modification of biologics with polyethylene glycol (PEG) or small molecule drugs requires extensive experience in chemistry and a high understanding of biologics. celares GmbH combines both and offers this expertise to clients.
celares GmbH offers services for the chemical modification of biologics including feasibility studies, process development and analytical methods.
Polymer structure, linker length or activation group may be synthesised tailored to each specific application.
ADCs combine the desirable properties of monoclonal antibodies, with the cell killing activity of cytotoxic drugs.
Recombinant protein production from scratch to GMP production is offered in collaboration with Scil Proteins GmbH.